MOLOGEN Lifescience AG

€2.80As of Sun 8 Nov 2026, 12:00 UTC
FRA:U1DAFinancials
Country Germany
PE (Fwd) •••
TSR 10Y CAGR (30.67%)
Div yield —
ROE —
Asset Management
Beta (5Y) 0.32
PE TTM —
TSR TTM 27.27%
Mkt cap €3.864M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
€3.55
26.95%
89.73%
Hold 5|7|10|7|2
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.03
0.03
0.04
0.04
12.27%
8.40%
12.96%
24.30%
Revenue€M
0.352
0.365
0.364
0.360
1.45%
6.62%
4.32%
3.18%
Peers (US$4.339M)
Cap (US$)
PE
8.547M
—
Capital
TTM
5Y
10Y
Leveragex
0.306
(0.344)
(0.278)
EBIT/Intx
0.347
0.701
0.683
Own earn%
(70.99)
(33.87)
(21.92)
Sh yield%
35.78
20.55
21.58
Owners
Insiders/Inst%
0.96
21.35
Short interest%
5.08
SBC / revenue%
0.20
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
0–2
$1 testx
—
Incr. ROIC%
−1